Search

Displaying results 91 - 100 of 8515 in total
  1. Drug

    Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle (VLP) vaccine

    go.drugbank.com/drugs/DB16431
    Experimental

    Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV-2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated

    Synonyms: RBD SARS-CoV-2 HBsAg VLP vaccine
  2. Drug

    BAY-876

    go.drugbank.com/drugs/DB16758
    Experimental

    Synonyms: BAY 876
  3. Drug

    Abdavomeran

    go.drugbank.com/drugs/DB15695
    Investigational

    [L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein together with a "foldon" trimerization domain derived

    Synonyms: BNT162b1 SARS-CoV-2 Vaccine
  4. Drug

    SARS-CoV-2 Sclamp

    go.drugbank.com/drugs/DB15849
    Investigational

    The University of Queensland (UQ), in partnership with The Coalition for Epidemic Preparedeness Inovations (CEPI) and CSL has developed a COVID-19 candidate, SARS-CoV-2 Sclamp. … The SARS-CoV-2 Sclamp Vaccine was developed within 3 weeks and moved immediately into preclinical testing through partnership with Dutch company, Viroclinics Xplore.

    Synonyms: UQ-1-SARS-CoV-2-Sclamp, SARS-CoV-2 Sclamp adjuvanted vaccine
  5. Drug

    Umirolimus

    go.drugbank.com/drugs/DB15527
    Experimental

    Products: Ba9
  6. Drug

    Migalastat

    go.drugbank.com/drugs/DB05018
    ApprovedInvestigational

    [L47036,L47057,L4274,L4278] Additionally, Galafold was also granted Priority Review designation, under which the FDA’s goal is to take action on an application within six months of application filing … [L47036,L47057] As of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and

    Synonyms: GR181413A free base
  7. Drug

    5-O-phosphono-alpha-D-ribofuranosyl diphosphate

    go.drugbank.com/drugs/DB01632
    ApprovedWithdrawn

    The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides.

    Synonyms: PRib-PP
  8. Drug

    Silver cation

    go.drugbank.com/drugs/DB14521
    Investigational

    Products: Silver ion disinfectant NANO SILVER ANTI-BAC
  9. Drug

    Lidocaine

    go.drugbank.com/drugs/DB00281
    ApprovedInvestigationalVet approved

    As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468]. … Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication [T583].

    Mixtures: Base Laboratories Numb Gel, Base Numb Topical AnorectalProducts: Base Laboratories Base Numb Topical Anorectal Cream, Base Laboratories Base Numb Extra Strength Topical Anorectal
  10. Drug

    BNT162a1 SARS-CoV-2 Vaccine

    go.drugbank.com/drugs/DB15697
    Experimental

    BNT162a1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech. BNT162a1 is a uridine mRNA (uRNA) vaccine formulated in lipid nanoparticles for delivery via ...

    Synonyms: BNT162a1 SARS-CoV-2 Vaccine